Tapewire

Nasdaq · USD

CMMB

Chemomab Therapeutics Ltd.

Export transactions ↓
Tapewire entity
7653
SEC CIK
0001534248
Parsed reports
83

Last 12 months

Inside the activity.

2 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202620
Jun 202600
Jul 202600
Aug 202602
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 16, 2021 Filed Mar 18, 2021 21:42 UTC
THIEL PETER10% owner
PurchaseAmerican Depositary Shares 230,536 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-021966 · doc4.xml · nonDerivative · entry 1

THIEL PETER · CIK 0001211060 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 1,108,509

F1 · kind: The purchase reported herein was made in a private placement transaction entered into directly with the Issuer.

F2 · shares: Each American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares of the Issuer.

F3 · price: Reported securities purchased in the private placement transaction as one ADS and one-tenth of one warrant (each whole warrant exercisable to purchase one ADS) for a combined price of $17.3509 per unit.

F2 · balance_after: Each American Depositary Share ("ADS") currently represents twenty (20) Ordinary Shares of the Issuer.

F4 · ownership.nature: These securities are held of record by Rivendell Investments 2017-9 LLC. The Reporting Person is the beneficial owner of Rivendell Investments 2017-9 LLC and has sole voting and investment power over the securities held by Rivendell Investments 2017-9 LLC.

Read SEC document
July 16, 2020 Filed Mar 11, 2021 23:33 UTC
Cohen Neil HarrisDirector · interim CEO
GrantStock Option (right to buy) · Derivative 55,000 $0.00 Strike: $0.17 $0.00
Disclosure

SEC source: 0001209191-21-019929 · doc4.xml · derivative · entry 1

Cohen Neil Harris · CIK 0001840006 · Director · interim CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Ordinary Shares · 55,000 shares

Expires 2030-07-15

F1 · derivative.exercise_date: 25% of shares underlying the option vests on July 16, 2021, and 12.5% of the remaining shares underlying the option vest in eight equal quarterly installments thereafter.

Read SEC document
July 16, 2020 Filed Mar 12, 2021 21:28 UTC GrantStock Option (right to buy) · Derivative 55,000 $0.00 Strike: $0.17 $0.00
Disclosure

SEC source: 0001209191-21-020164 · doc4.xml · derivative · entry 1

Polovets Stanislav · CIK 0001847625 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Ordinary Shares · 55,000 shares

Expires 2030-07-15

F1 · derivative.exercise_date: 25% of shares underlying the option vests on July 16, 2021, and 12.5% of the remaining shares underlying the option vest in eight equal quarterly installments thereafter.

Read SEC document
July 16, 2020 Filed Sep 1, 2026 14:05 UTC GrantStock option (right to buy American Depositary Shares) · Derivative 172 $0.00 Strike: $52.80 $0.00
Disclosure

SEC source: 0001178913-26-004371 · ownership.xml · derivative · entry 3

Cohen Neil Harris · CIK 0001840006 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172

Underlying: American Depositary Shares · 172 shares

Expires 2030-07-16

F1 · derivative.exercise_date: The options reported in this row were granted to the Reporting Person by the Issuer on July 16, 2020, and are fully vested and exercisable as of the date of this report.

Read SEC document
March 15, 2018 Filed Nov 17, 2022 21:56 UTC
Mor George AdiDirector · Chief Scientific Officer
GrantOption to Purchase American Depositary Shares · Derivative 131,698 $0.00 Strike: $1.49 $0.00
Disclosure

SEC source: 0001178913-22-004098 · ownership.xml · derivative · entry 3

Mor George Adi · CIK 0001851069 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,698

Underlying: American Depositary Shares · 131,698 shares

Expires 2028-03-15

F3 · security: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

F4 · derivative.exercise_date: These options have vested and are exercisable as of the date hereof.

F1 · derivative.underlying: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.

Read SEC document
March 15, 2018 Filed Jan 5, 2023 21:01 UTC
Mor George AdiDirector · Chief Scientific Officer
GrantOption to Purchase American Depositary Shares · Derivative 131,698 $0.00 Strike: $1.49 $0.00
Disclosure

SEC source: 0001178913-23-000076 · ownership.xml · derivative · entry 3

Mor George Adi · CIK 0001851069 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 131,698

Underlying: American Depositary Shares · 131,698 shares

Expires 2028-03-15

F3 · security: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

F4 · derivative.exercise_date: These options have vested and are exercisable as of the date hereof.

F1 · derivative.underlying: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.

Read SEC document
October 28, 2016 Filed Nov 17, 2022 21:56 UTC
Mor George AdiDirector · Chief Scientific Officer
GrantOption to Purchase American Depositary Shares · Derivative 33,725 $0.00 Strike: $0.80 $0.00
Disclosure

SEC source: 0001178913-22-004098 · ownership.xml · derivative · entry 4

Mor George Adi · CIK 0001851069 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Kobi George, the Reporting Person's spouse

Disclosed balance after: 33,725

Underlying: American Depositary Shares · 33,725 shares

Expires 2026-10-27

F3 · security: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

F5 · derivative.exercise_date: These options have vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service.

F1 · derivative.underlying: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.

Read SEC document
October 28, 2016 Filed Jan 5, 2023 21:01 UTC
Mor George AdiDirector · Chief Scientific Officer
GrantOption to Purchase American Depositary Shares · Derivative 33,725 $0.00 Strike: $0.80 $0.00
Disclosure

SEC source: 0001178913-23-000076 · ownership.xml · derivative · entry 4

Mor George Adi · CIK 0001851069 · Director · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Kobi George, the Reporting Person's spouse

Disclosed balance after: 33,725

Underlying: American Depositary Shares · 33,725 shares

Expires 2026-10-27

F3 · security: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

F5 · derivative.exercise_date: These options have vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service.

F1 · derivative.underlying: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.

Read SEC document
October 28, 2016 Filed Mar 23, 2023 11:33 UTC GrantOption to Purchase American Depositary Shares · Derivative 10,123 $0.00 Strike: $0.80 $0.00
Disclosure

SEC source: 0001178913-23-001109 · zk2329427.xml · derivative · entry 5

Darvish Nissim · CIK 0001793602 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,123

Underlying: American Depositary Shares · 10,123 shares

Expires 2017-10-27

F2 · security: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

F6 · derivative.exercise_date: The options reported in this row have all vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service.

F1 · derivative.underlying: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.

Read SEC document
October 28, 2016 Filed Jul 5, 2023 21:48 UTC GrantOption to Purchase American Depositary Shares · Derivative 10,123 $0.00 Strike: $0.80 $0.00
Disclosure

SEC source: 0001178913-23-002370 · zk2329945.xml · derivative · entry 6

Darvish Nissim · CIK 0001793602 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,123

Underlying: American Depositary Shares · 10,123 shares

Expires 2017-10-27

F1 · security: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

F2 · security: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.

F7 · derivative.exercise_date: The options reported in this row have all vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service.

F2 · derivative.underlying: Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.